William Koller

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Chemicals & Drugs

Procedures

Anatomy

Concepts & Ideas

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Hälbig T D; Tse W; Frisina P G; Baker B R; Hollander E; Shapiro H; Tagliati M; Koller W C; Olanow C W
Subthalamic deep brain stimulation and impulse control in Parkinson's disease.
Tse Winona; Frisina Pasquale G; Hälbig Thomas D; Gracies Jean-Michel; Liang Lisa; Tarshish Chaim; Lesser Gerson; Neufeld Richard; Koller William C; Libow Leslie S
The effects of withdrawal of dopaminergic medication in nursing home patients with advanced parkinsonism.
Tse Winona; Libow Leslie S; Neufeld Richard; Lesser Gerson; Frank Judith; Dolan Susan; Tarshish Chaim; Gracies Jean-Michel; Olanow C Warren; Koller William C; Hälbig Thomas D
Prevalence of movement disorders in an elderly nursing home population.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of William Koller (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Hälbig T D; Tse W; Frisina P G; Baker B R; Hollander E; Shapiro H; Tagliati M; Koller W C; Olanow C W
Subthalamic deep brain stimulation and impulse control in Parkinson's disease.
European journal of neurology : the official journal of the European Federation of Neurological Societies 2009;16(4):493-7.
2008: Tse Winona; Frisina Pasquale G; Hälbig Thomas D; Gracies Jean-Michel; Liang Lisa; Tarshish Chaim; Lesser Gerson; Neufeld Richard; Koller William C; Libow Leslie S
The effects of withdrawal of dopaminergic medication in nursing home patients with advanced parkinsonism.
Journal of the American Medical Directors Association 2008;9(9):670-5.
2008: Tse Winona; Libow Leslie S; Neufeld Richard; Lesser Gerson; Frank Judith; Dolan Susan; Tarshish Chaim; Gracies Jean-Michel; Olanow C Warren; Koller William C; Hälbig Thomas D
Prevalence of movement disorders in an elderly nursing home population.
Archives of gerontology and geriatrics 2008;46(3):359-66.
2007: Pahwa Rajesh; Koller William C; Trosch Richard M; Sherry James H;
Subcutaneous apomorphine in patients with advanced Parkinson's disease: a dose-escalation study with randomized, double-blind, placebo-controlled crossover evaluation of a single dose.
Journal of the neurological sciences 2007;258(1-2):137-43.
2007: Bowler Rosemarie M; Nakagawa Sanae; Drezgic Marija; Roels Harry A; Park Robert M; Diamond Emily; Mergler Donna; Bouchard Maryse; Bowler Russell P; Koller William
Sequelae of fume exposure in confined space welding: a neurological and neuropsychological case series.
Neurotoxicology 2007;28(2):298-311.
2007: Bowler Rosemarie M; Roels Harry A; Nakagawa Sanae; Drezgic Marija; Diamond Emily; Park Robert; Koller William; Bowler Russell P; Mergler Donna; Bouchard Maryse; Smith Donald; Gwiazda Roberto; Doty Richard L
Dose-effect relationships between manganese exposure and neurological, neuropsychological and pulmonary function in confined space bridge welders.
Occupational and environmental medicine 2007;64(3):167-77.
2007: Hälbig Thomas D; Koller William C
Levodopa.
Handbook of clinical neurology / edited by P.J. Vinken and G.W. Bruyn 2007;84():31-72.
2007: Koller William C; Melamed Eldad
Preface.
Handbook of clinical neurology / edited by P.J. Vinken and G.W. Bruyn 2007;84():IX.
2007: Koller William C; Melamed Eldad
Preface.
Handbook of clinical neurology / edited by P.J. Vinken and G.W. Bruyn 2007;83():IX.
2006: Tröster Alexander I; Fields Julie A; Paolo Anthony M; Koller William C
Absence of the apolipoprotein E epsilon4 allele is associated with working memory impairment in Parkinson's disease.
Journal of the neurological sciences 2006;248(1-2):62-7.
2006: Chaudhuri Kallol Ray; Martinez-Martin Pablo; Schapira Anthony H V; Stocchi Fabrizio; Sethi Kapil; Odin Per; Brown Richard G; Koller William; Barone Paolo; MacPhee Graeme; Kelly Linda; Rabey Martin; MacMahon Doug; Thomas Sue; Ondo William; Rye David; Forbes Alison; Tluk Susanne; Dhawan Vandana; Bowron Annette; Williams Adrian J; Olanow Charles W
International multicenter pilot study of the first comprehensive self-completed nonmotor symptoms questionnaire for Parkinson's disease: the NMSQuest study.
Movement disorders : official journal of the Movement Disorder Society 2006;21(7):916-23.
2006: Bowler Rosemarie M; Koller William; Schulz Paul E
Parkinsonism due to manganism in a welder: neurological and neuropsychological sequelae.
Neurotoxicology 2006;27(3):327-32.
2006: Cersosimo Maria G; Koller William C
The diagnosis of manganese-induced parkinsonism.
Neurotoxicology 2006;27(3):340-6.
2006: Ondo W G; Jankovic J; Connor G S; Pahwa R; Elble R; Stacy M A; Koller W C; Schwarzman L; Wu S-C; Hulihan J F;
Topiramate in essential tremor: a double-blind, placebo-controlled trial.
Neurology 2006;66(5):672-7.
2005: Tse Winona; Liu Yiming; Barthlen Gabriele M; Hälbig Thomas D; Tolgyesi Sonia V; Gracies Jean-Michel; Olanow C Warren; Koller William C
Clinical usefulness of the Parkinson's disease sleep scale.
Parkinsonism & related disorders 2005;11(5):317-21.
2005: Alvarez L; Macias R; Lopez G; Alvarez E; Pavon N; Rodriguez-Oroz M C; Juncos J L; Maragoto C; Guridi J; Litvan I; Tolosa E S; Koller W; Vitek J; DeLong M R; Obeso J A
Bilateral subthalamotomy in Parkinson's disease: initial and long-term response.
Brain : a journal of neurology 2005;128(Pt 3):570-83.
2005: Koller W; Guarnieri M; Hubble J; Rabinowicz A L; Silver D
An open-label evaluation of the tolerability and safety of Stalevo (carbidopa, levodopa and entacapone) in Parkinson's disease patients experiencing wearing-off.
Journal of neural transmission (Vienna, Austria : 1996) 2005;112(2):221-30.
2004: Tetrud James W; Koller William C
A novel formulation of selegiline for the treatment of Parkinson's disease.
Neurology 2004;63(7 Suppl 2):S2-6.
2004: Tse Winona; Cersosimo Maria G; Gracies Jean-Michel; Morgello Susan; Olanow C Warren; Koller William
Movement disorders and AIDS: a review.
Parkinsonism & related disorders 2004;10(6):323-34.
2004: Germano Isabelle M; Gracies Jean-Michel; Weisz Donald J; Tse Winona; Koller William C; Olanow C Warren
Unilateral stimulation of the subthalamic nucleus in Parkinson disease: a double-blind 12-month evaluation study.
Journal of neurosurgery 2004;101(1):36-42.
2004: Koller William C; Cersosimo Maria G
Neuroprotection in Parkinson's disease: an elusive goal.
Current neurology and neuroscience reports 2004;4(4):277-83.
2004: Li Y J; Hauser M A; Scott W K; Martin E R; Booze M W; Qin X J; Walter J W; Nance M A; Hubble J P; Koller W C; Pahwa R; Stern M B; Hiner B C; Jankovic J; Goetz C G; Small G W; Mastaglia F; Haines J L; Pericak-Vance M A; Vance J M
Apolipoprotein E controls the risk and age at onset of Parkinson disease.
Neurology 2004;62(11):2005-9.
2004: Koller William; Stacy Mark
Other formulations and future considerations for apomorphine for subcutaneous injection therapy.
Neurology 2004;62(6 Suppl 4):S22-6.
2004: Koller William C; Lyons Kelly E; Truly William
Effect of levodopa treatment for parkinsonism in welders: A double-blind study.
Neurology 2004;62(5):730-3.
2004: Tse Winona; Koller William
Reply to "declining medication requirement in some patients with advanced Parkinson disease and dementia".
Clinical neuropharmacology 2004;27(1):3.
2004: Koller William C; Tse Winona
Unmet medical needs in Parkinson's disease.
Neurology 2004;62(1 Suppl 1):S1-8.
2003: Li Yi-Ju; Oliveira Sofia A; Xu Puting; Martin Eden R; Stenger Judith E; Scherzer Clemens R; Hauser Michael A; Scott William K; Small Gary W; Nance Martha A; Watts Ray L; Hubble Jean P; Koller William C; Pahwa Rajesh; Stern Mathew B; Hiner Bradley C; Jankovic Joseph; Goetz Christopher G; Mastaglia Frank; Middleton Lefkos T; Roses Allen D; Saunders Ann M; Schmechel Donald E; Gullans Steven R; Haines Jonathan L; Gilbert John R; Vance Jeffery M; Pericak-Vance Margaret A; Hulette Christine; Welsh-Bohmer Kathleen A
Glutathione S-transferase omega-1 modifies age-at-onset of Alzheimer disease and Parkinson disease.
Human molecular genetics 2003;12(24):3259-67.
2003: Oliveira Sofia A; Scott William K; Nance Martha A; Watts Ray L; Hubble Jean P; Koller William C; Lyons Kelly E; Pahwa Rajesh; Stern Matthew B; Hiner Bradley C; Jankovic Joseph; Ondo William G; Allen Fred H; Scott Burton L; Goetz Christopher G; Small Gary W; Mastaglia Frank L; Stajich Jeffrey M; Zhang Fengyu; Booze Michael W; Reaves Joshua A; Middleton Lefkos T; Haines Jonathan L; Pericak-Vance Margaret A; Vance Jeffery M; Martin Eden R
Association study of Parkin gene polymorphisms with idiopathic Parkinson disease.
Archives of neurology 2003;60(7):975-80.
2003: Cersosimo Maria Graciela; Koller William C
Movement disorders.
The Medical clinics of North America 2003;87(4):771-91, vii.
2003: Oliveira Sofia A; Scott William K; Martin Eden R; Nance Martha A; Watts Ray L; Hubble Jean P; Koller William C; Pahwa Rajesh; Stern Matthew B; Hiner Bradley C; Ondo William G; Allen Fred H; Scott Burton L; Goetz Christopher G; Small Gary W; Mastaglia Frank; Stajich Jeffrey M; Zhang Fengyu; Booze Michael W; Winn Michelle P; Middleton Lefkos T; Haines Jonathan L; Pericak-Vance Margaret A; Vance Jeffery M
Parkin mutations and susceptibility alleles in late-onset Parkinson's disease.
Annals of neurology 2003;53(5):624-9.
2003: van der Walt J M; Martin E R; Scott W K; Zhang F; Nance M A; Watts R L; Hubble J P; Haines J L; Koller W C; Lyons K; Pahwa R; Stern M B; Colcher A; Hiner B C; Jankovic J; Ondo W G; Allen F H; Goetz C G; Small G W; Mastaglia F; Roses A D; Stajich J M; Booze M W; Fujiwara K; Gibson R A; Middleton L T; Scott B L; Pericak-Vance M A; Vance J M
Genetic polymorphisms of the N-acetyltransferase genes and risk of Parkinson's disease.
Neurology 2003;60(7):1189-91.
2003: van der Walt Joelle M; Nicodemus Kristin K; Martin Eden R; Scott William K; Nance Martha A; Watts Ray L; Hubble Jean P; Haines Jonathan L; Koller William C; Lyons Kelly; Pahwa Rajesh; Stern Matthew B; Colcher Amy; Hiner Bradley C; Jankovic Joseph; Ondo William G; Allen Fred H; Goetz Christopher G; Small Gary W; Mastaglia Frank; Stajich Jeffrey M; McLaurin Adam C; Middleton Lefkos T; Scott Burton L; Schmechel Donald E; Pericak-Vance Margaret A; Vance Jeffery M
Mitochondrial polymorphisms significantly reduce the risk of Parkinson disease.
American journal of human genetics 2003;72(4):804-11.
2003: Fields J A; Tröster A I; Woods S P; Higginson C I; Wilkinson S B; Lyons K E; Koller W C; Pahwa R
Neuropsychological and quality of life outcomes 12 months after unilateral thalamic stimulation for essential tremor.
Journal of neurology, neurosurgery, and psychiatry 2003;74(3):305-11.
2003: Tröster Alexander I; Fields Julie A; Wilkinson Steven; Pahwa Rajesh; Koller William C; Lyons Kelly E
Effect of motor improvement on quality of life following subthalamic stimulation is mediated by changes in depressive symptomatology.
Stereotactic and functional neurosurgery 2003;80(1-4):43-7.
2003: Lyons Kelly E; Pahwa Rajesh; Comella Cynthia L; Eisa Mahmood S; Elble Rodger J; Fahn Stanley; Jankovic Joseph; Juncos Jorge L; Koller William C; Ondo William G; Sethi Kapil D; Stern Matthew B; Tanner Caroline M; Tintner Ron; Watts Ray L
Benefits and risks of pharmacological treatments for essential tremor.
Drug safety : an international journal of medical toxicology and drug experience 2003;26(7):461-81.
2003: Facca Alicia G; Koller William C
Differential diagnosis of parkinsonism.
Advances in neurology 2003;91():383-96.
2002: Poorkaj Parvoneh; Muma Nancy A; Zhukareva Victoria; Cochran Elizabeth J; Shannon Kathleen M; Hurtig Howard; Koller William C; Bird Thomas D; Trojanowski John Q; Lee Virginia M-Y; Schellenberg Gerard D
An R5L tau mutation in a subject with a progressive supranuclear palsy phenotype.
Annals of neurology 2002;52(4):511-6.
2002: Rascol Olivier; Goetz Christopher; Koller William; Poewe Werner; Sampaio Cristina
Treatment interventions for Parkinson's disease: an evidence based assessment.
Lancet 2002;359(9317):1589-98.
2002: Perlmutter J S; Mink J W; Bastian A J; Zackowski K; Hershey T; Miyawaki E; Koller W; Videen T O
Blood flow responses to deep brain stimulation of thalamus.
Neurology 2002;58(9):1388-94.
2002: Li Yi-Ju; Scott William K; Hedges Dale J; Zhang Fengyu; Gaskell P Craig; Nance Martha A; Watts Ray L; Hubble Jean P; Koller William C; Pahwa Rajesh; Stern Matthew B; Hiner Bradley C; Jankovic Joseph; Allen Fred A; Goetz Christopher G; Mastaglia Frank; Stajich Jeffrey M; Gibson Rachel A; Middleton Lefkos T; Saunders Ann M; Scott Burton L; Small Gary W; Nicodemus Kristin K; Reed Allison D; Schmechel Donald E; Welsh-Bohmer Kathleen A; Conneally P Michael; Roses Allen D; Gilbert John R; Vance Jeffery M; Haines Jonathan L; Pericak-Vance Margaret A
Age at onset in two common neurodegenerative diseases is genetically controlled.
American journal of human genetics 2002;70(4):985-93.
2002: Pahwa Rajesh; Lyons Kelly E; Kempf Lucas; Wilkinson Steven B; Koller William C
Thalamic stimulation for midbrain tremor after partial hemangioma resection.
Movement disorders : official journal of the Movement Disorder Society 2002;17(2):404-7.
2002: Tröster A I; Woods S P; Fields J A; Lyons K E; Pahwa R; Higginson C I; Koller W C
Neuropsychological deficits in essential tremor: an expression of cerebello-thalamo-cortical pathophysiology?
European journal of neurology : the official journal of the European Federation of Neurological Societies 2002;9(2):143-51.
2002: Koller William C
Treatment of early Parkinson's disease.
Neurology 2002;58(4 Suppl 1):S79-86.
2002: Zackowski K M; Bastian A J; Hakimian S; Mink J W; Perlmutter J S; Koller W C; Thach W T
Thalamic stimulation reduces essential tremor but not the delayed antagonist muscle timing.
Neurology 2002;58(3):402-10.
2001: Woods S P; Fields J A; Lyons K E; Koller W C; Wilkinson S B; Pahwa R; Tröster A I
Neuropsychological and quality of life changes following unilateral thalamic deep brain stimulation in Parkinson's disease: a one-year follow-up.
Acta neurochirurgica 2001;143(12):1273-7; discussion 1278.
2001: Martin E R; Scott W K; Nance M A; Watts R L; Hubble J P; Koller W C; Lyons K; Pahwa R; Stern M B; Colcher A; Hiner B C; Jankovic J; Ondo W G; Allen F H; Goetz C G; Small G W; Masterman D; Mastaglia F; Laing N G; Stajich J M; Ribble R C; Booze M W; Rogala A; Hauser M A; Zhang F; Gibson R A; Middleton L T; Roses A D; Haines J L; Scott B L; Pericak-Vance M A; Vance J M
Association of single-nucleotide polymorphisms of the tau gene with late-onset Parkinson disease.
JAMA : the journal of the American Medical Association 2001;286(18):2245-50.
2001: Scott W K; Nance M A; Watts R L; Hubble J P; Koller W C; Lyons K; Pahwa R; Stern M B; Colcher A; Hiner B C; Jankovic J; Ondo W G; Allen F H; Goetz C G; Small G W; Masterman D; Mastaglia F; Laing N G; Stajich J M; Slotterbeck B; Booze M W; Ribble R C; Rampersaud E; West S G; Gibson R A; Middleton L T; Roses A D; Haines J L; Scott B L; Vance J M; Pericak-Vance M A
Complete genomic screen in Parkinson disease: evidence for multiple genes.
JAMA : the journal of the American Medical Association 2001;286(18):2239-44.
2001: Lyons K E; Koller W C; Wilkinson S B; Pahwa R
Long term safety and efficacy of unilateral deep brain stimulation of the thalamus for parkinsonian tremor.
Journal of neurology, neurosurgery, and psychiatry 2001;71(5):682-4.
2001: Tanner C M; Goldman S M; Lyons K E; Aston D A; Tetrud J W; Welsh M D; Langston J W; Koller W C
Essential tremor in twins: an assessment of genetic vs environmental determinants of etiology.
Neurology 2001;57(8):1389-91.
2001: Koller W; Lees A; Doder M; Hely M;
Randomized trial of tolcapone versus pergolide as add-on to levodopa therapy in Parkinson's disease patients with motor fluctuations.
Movement disorders : official journal of the Movement Disorder Society 2001;16(5):858-66.
2001: Marjama-Lyons J M; Koller W C
Parkinson's disease. Update in diagnosis and symptom management.
Geriatrics 2001;56(8):24-5, 29-30, 33-5.
2001: Fukuda M; Mentis M J; Ma Y; Dhawan V; Antonini A; Lang A E; Lozano A M; Hammerstad J; Lyons K; Koller W C; Moeller J R; Eidelberg D
Networks mediating the clinical effects of pallidal brain stimulation for Parkinson's disease: a PET study of resting-state glucose metabolism.
Brain : a journal of neurology 2001;124(Pt 8):1601-9.
2001: Olanow C W; Watts R L; Koller W C
An algorithm (decision tree) for the management of Parkinson's disease (2001): treatment guidelines.
Neurology 2001;56(11 Suppl 5):S1-S88.
2001: Brin M F; Lyons K E; Doucette J; Adler C H; Caviness J N; Comella C L; Dubinsky R M; Friedman J H; Manyam B V; Matsumoto J Y; Pullman S L; Rajput A H; Sethi K D; Tanner C; Koller W C
A randomized, double masked, controlled trial of botulinum toxin type A in essential hand tremor.
Neurology 2001;56(11):1523-8.
2001: Koller W C; Lyons K E; Wilkinson S B; Troster A I; Pahwa R
Long-term safety and efficacy of unilateral deep brain stimulation of the thalamus in essential tremor.
Movement disorders : official journal of the Movement Disorder Society 2001;16(3):464-8.
2001: Hutton J T; Metman L V; Chase T N; Juncos J L; Koller W C; Pahwa R; LeWitt P A; Samii A; Tsui J K; Calne D B; Waters C H; Calabrese V P; Bennett J P; Barrett R; Morris J L
Transdermal dopaminergic D(2) receptor agonist therapy in Parkinson's disease with N-0923 TDS: a double-blind, placebo-controlled study.
Movement disorders : official journal of the Movement Disorder Society 2001;16(3):459-63.
2001: Heikkinen H; Nutt J G; LeWitt P A; Koller W C; Gordin A
The effects of different repeated doses of entacapone on the pharmacokinetics of L-Dopa and on the clinical response to L-Dopa in Parkinson's disease.
Clinical neuropharmacology 2001;24(3):150-7.
2001: Fukuda M; Mentis M; Ghilardi M F; Dhawan V; Antonini A; Hammerstad J; Lozano A M; Lang A; Lyons K; Koller W; Ghez C; Eidelberg D
Functional correlates of pallidal stimulation for Parkinson's disease.
Annals of neurology 2001;49(2):155-64.
2001: Pahwa R; Lyons K E; Wilkinson S B; Tröster A I; Overman J; Kieltyka J; Koller W C
Comparison of thalamotomy to deep brain stimulation of the thalamus in essential tremor.
Movement disorders : official journal of the Movement Disorder Society 2001;16(1):140-3.
2001: Milligan B D; Wilkinson S; Overman J; Kirschman D L; Koller W C; Pahwa R; Lyons K E; Batnitzky S; Gordon M A
Magnitude of microelectrode refinement in pallidotomy and thalamotomy.
Stereotactic and functional neurosurgery 2001;76(1):2-18.
2000: Hristova A H; Koller W C
Early Parkinson's disease: what is the best approach to treatment.
Drugs & aging 2000;17(3):165-81.
2000: Hristova A; Lyons K; Tröster A I; Pahwa R; Wilkinson S B; Koller W C
Effect and time course of deep brain stimulation of the globus pallidus and subthalamus on motor features of Parkinson's disease.
Clinical neuropharmacology 2000;23(4):208-11.
2000: Milanov I; Kmetski T S; Lyons K E; Koller W C
Prevalence of Parkinson's disease in Bulgarian Gypsies.
Neuroepidemiology 2000;19(4):206-9.
2000: Hubble J; Koller W C; Atchison P; Taylor A C; Citerone D R; Zussman B D; Friedman C J; Hawker N
Linear pharmacokinetic behavior of ropinirole during multiple dosing in patients with Parkinson's disease.
Journal of clinical pharmacology 2000;40(6):641-6.
2000: Montgomery E B; Baker K B; Lyons K; Koller W C
Motor initiation and execution in essential tremor and Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 2000;15(3):511-5.
2000: Hauser R A; Koller W C; Hubble J P; Malapira T; Busenbark K; Olanow C W
Time course of loss of clinical benefit following withdrawal of levodopa/carbidopa and bromocriptine in early Parkinson' s disease.
Movement disorders : official journal of the Movement Disorder Society 2000;15(3):485-9.
2000: Montgomery E B; Lyons K; Koller W C
Early detection of probable idiopathic Parkinson's disease: II. A prospective application of a diagnostic test battery.
Movement disorders : official journal of the Movement Disorder Society 2000;15(3):474-8.
2000: Montgomery E B; Koller W C; LaMantia T J; Newman M C; Swanson-Hyland E; Kaszniak A W; Lyons K
Early detection of probable idiopathic Parkinson's disease: I. Development of a diagnostic test battery.
Movement disorders : official journal of the Movement Disorder Society 2000;15(3):467-73.
2000: Marjama-Lyons J; Koller W
Tremor-predominant Parkinson's disease. Approaches to treatment.
Drugs & aging 2000;16(4):273-8.
2000: Miyawaki E; Perlmutter J S; Tröster A I; Videen T O; Koller W C
The behavioral complications of pallidal stimulation: a case report.
Brain and cognition 2000;42(3):417-34.
2000: Straits-Tröster K; Fields J A; Wilkinson S B; Pahwa R; Lyons K E; Koller W C; Tröster A I
Health-related quality of life in Parkinson's disease after pallidotomy and deep brain stimulation.
Brain and cognition 2000;42(3):399-416.
2000: Kirschman D L; Milligan B; Wilkinson S; Overman J; Wetzel L; Batnitzky S; Lyons K; Pahwah R; Koller W C; Gordon M A
Pallidotomy microelectrode targeting: neurophysiology-based target refinement.
Neurosurgery 2000;46(3):613-22; discussion 622-4.
2000: Koller W C; Pahwa P R; Lyons K E; Wilkinson S B
Deep brain stimulation of the Vim nucleus of the thalamus for the treatment of tremor.
Neurology 2000;55(12 Suppl 6):S29-33.
2000: Koller W C
Levodopa in the treatment of Parkinson's disease.
Neurology 2000;55(11 Suppl 4):S2-7; discussion S8-12.
2000: Pahwa R; Lyons K; Koller W C
Surgical treatment of essential tremor.
Neurology 2000;54(11 Suppl 4):S39-44.
2000: Koller W C; Hristova A; Brin M
Pharmacologic treatment of essential tremor.
Neurology 2000;54(11 Suppl 4):S30-8.
2000: Bain P; Brin M; Deuschl G; Elble R; Jankovic J; Findley L; Koller W C; Pahwa R
Criteria for the diagnosis of essential tremor.
Neurology 2000;54(11 Suppl 4):S7.
2000: Deuschl G; Koller W C
Introduction. Essential tremor.
Neurology 2000;54(11 Suppl 4):S1.
1999: Agid Y; Ahlskog E; Albanese A; Calne D; Chase T; De Yebenes J; Factor S; Fahn S; Gershanik O; Goetz C; Koller W; Kurth M; Lang A; Lees A; Lewitt P; Marsden D; Melamed E; Michel P P; Mizuno Y; Obeso J; Oertel W; Olanow W; Poewe W; Pollak P; Tolosa E
Levodopa in the treatment of Parkinson's disease: a consensus meeting.
Movement disorders : official journal of the Movement Disorder Society 1999;14(6):911-3.
1999: Tröster A I; Fields J A; Pahwa R; Wilkinson S B; Strait-Tröster K A; Lyons K; Kieltyka J; Koller W C
Neuropsychological and quality of life outcome after thalamic stimulation for essential tremor.
Neurology 1999;53(8):1774-80.
1999: Pahwa R; Lyons K L; Wilkinson S B; Carpenter M A; Tröster A I; Searl J P; Overman J; Pickering S; Koller W C
Bilateral thalamic stimulation for the treatment of essential tremor.
Neurology 1999;53(7):1447-50.
1999: Hogan T; Grimaldi R; Dingemanse J; Martin M; Lyons K; Koller W
The Parkinson's disease symptom inventory (PDSI): a comprehensive and sensitive instrument to measure disease symptoms and treatment side-effects.
Parkinsonism & related disorders 1999;5(3):93-8.
1999: Scott W K; Yamaoka L H; Stajich J M; Scott B L; Vance J M; Roses A D; Pericak-Vance M A; Watts R L; Nance M; Hubble J; Koller W; Stern M B; Colcher A; Allen F H; Hiner B C; Jankovic J; Ondo W; Laing N G; Mastaglia F; Goetz C; Pappert E; Small G W; Masterman D; Haines J L; Davies T L
The alpha-synuclein gene is not a major risk factor in familial Parkinson disease.
Neurogenetics 1999;2(3):191-2.
1999: Fields J A; Tröster A I; Wilkinson S B; Pahwa R; Koller W C
Cognitive outcome following staged bilateral pallidal stimulation for the treatment of Parkinson's disease.
Clinical neurology and neurosurgery 1999;101(3):182-8.
1999: Koller W C; Hutton J T; Tolosa E; Capilldeo R
Immediate-release and controlled-release carbidopa/levodopa in PD: a 5-year randomized multicenter study. Carbidopa/Levodopa Study Group.
Neurology 1999;53(5):1012-9.
1999: Koller W C; Lyons K E; Wilkinson S B; Pahwa R
Efficacy of unilateral deep brain stimulation of the VIM nucleus of the thalamus for essential head tremor.
Movement disorders : official journal of the Movement Disorder Society 1999;14(5):847-50.
1999: Piatt A L; Fields J A; Paolo A M; Koller W C; Tröster A I
Lexical, semantic, and action verbal fluency in Parkinson's disease with and without dementia.
Journal of clinical and experimental neuropsychology 1999;21(4):435-43.
1999: Koller W C; Pahwa R; Lyons K E; Albanese A
Surgical treatment of Parkinson's disease.
Journal of the neurological sciences 1999;167(1):1-10.
1999: Montgomery E B; Baker K B; Lyons K; Koller W C
Abnormal performance on the PD test battery by asymptomatic first-degree relatives.
Neurology 1999;52(4):757-62.
1999: Wszolek Z K; Koller W C
Rare and unusual parkinsonian syndromes.
Advances in neurology 1999;80():369-76.
1998: Tröster A I; Wilkinson S B; Fields J A; Miyawaki K; Koller W C
Chronic electrical stimulation of the left ventrointermediate (Vim) thalamic nucleus for the treatment of pharmacotherapy-resistant Parkinson's disease: a differential impact on access to semantic and episodic memory?
Brain and cognition 1998;38(2):125-49.
1998: Koller W C
Neuroprotection for Parkinson's disease.
Annals of neurology 1998;44(3 Suppl 1):S155-9.
1998: Tsao K; Wilkinson S; Overman J; Koller W C; Batnitzky S; Gordon M A
Pallidotomy lesion locations: significance of microelectrode refinement.
Neurosurgery 1998;43(3):506-12; discussion 512-3.
1998: Lyons K E; Pahwa R; Busenbark K L; Tröster A I; Wilkinson S; Koller W C
Improvements in daily functioning after deep brain stimulation of the thalamus for intractable tremor.
Movement disorders : official journal of the Movement Disorder Society 1998;13(4):690-2.
1998: Koller W C; Rueda M G
Mechanism of action of dopaminergic agents in Parkinson's disease.
Neurology 1998;50(6 Suppl 6):S11-4; discussion S44-8.
1998: Koller W C; Tolosa E
Current and emerging drug therapies in the management of Parkinson's disease.
Neurology 1998;50(6 Suppl 6):S1.
1998: Wasielewski P G; Koller W C
Quality of life and Parkinson's disease: the CR FIRST Study.
Journal of neurology 1998;245 Suppl 1():S28-30.
1998: Pahwa R; Lyons K; Hubble J P; Busenbark K; Rienerth J D; Pahwa A; Koller W C
Double-blind controlled trial of gabapentin in essential tremor.
Movement disorders : official journal of the Movement Disorder Society 1998;13(3):465-7.
1998: Trosch R M; Friedman J H; Lannon M C; Pahwa R; Smith D; Seeberger L C; O'Brien C F; LeWitt P A; Koller W C
Clozapine use in Parkinson's disease: a retrospective analysis of a large multicentered clinical experience.
Movement disorders : official journal of the Movement Disorder Society 1998;13(3):377-82.
1998: Koller W C; Wilkinson S; Pahwa R; Miyawaki E K
Surgical treatment options in Parkinson's disease.
Neurosurgery clinics of North America 1998;9(2):295-306.
1998: Lyons K E; Hubble J P; Tröster A I; Pahwa R; Koller W C
Gender differences in Parkinson's disease.
Clinical neuropharmacology 1998;21(2):118-21.
1998: Olanow C W; Koller W C
An algorithm (decision tree) for the management of Parkinson's disease: treatment guidelines. American Academy of Neurology.
Neurology 1998;50(3 Suppl 3):S1-57.
1998: Carpenter M A; Pahwa R; Miyawaki K L; Wilkinson S B; Searl J P; Koller W C
Reduction in voice tremor under thalamic stimulation.
Neurology 1998;50(3):796-8.
1998: Ellis R J; Jan K; Kawas C; Koller W C; Lyons K E; Jeste D V; Hansen L A; Thal L J
Diagnostic validity of the dementia questionnaire for Alzheimer disease.
Archives of neurology 1998;55(3):360-5.
1998: Pahwa R; Koller W C
Advances in the treatment of Parkinson's disease.
Drugs of today (Barcelona, Spain : 1998) 1998;34(2):95-105.
1998: Goodman S H; Wilkinson S; Overman J; Koller W C; Tröster A; Pahwa R; Lyons K; Kieltyka J; Burns J; Gordon M
Lesion volume and clinical outcome in stereotactic pallidotomy and thalamotomy.
Stereotactic and functional neurosurgery 1998;71(4):164-72.
1998: Tollefson T T; Burns J; Wilkinson S; Overman J; Kieltyka J; Goodman S H; Koller W C; Tröster A; Lyons K; Pahwa R; Batnitzky S; Wetzel L; Gordon M
Comparative magnetic resonance image-based evaluation of thalamotomy and pallidotomy lesion volumes.
Stereotactic and functional neurosurgery 1998;71(3):131-44.
1998: Tsao K; Wilkinson S; Overman J; Kieltyka J; Tollefson T; Koller W C; Pahwa R; Troster A I; Lyons K E; Batznitzky S; Wetzel L; Gordon M A
Comparison of actual pallidotomy lesion location with expected stereotactic location.
Stereotactic and functional neurosurgery 1998;71(1):1-19.
1998: Wasielewski P G; Burns J M; Koller W C
Pharmacologic treatment of tremor.
Movement disorders : official journal of the Movement Disorder Society 1998;13 Suppl 3():90-100.
1998: Brin M F; Koller W
Epidemiology and genetics of essential tremor.
Movement disorders : official journal of the Movement Disorder Society 1998;13 Suppl 3():55-63.
1998: Hubble J P; Kurth J H; Glatt S L; Kurth M C; Schellenberg G D; Hassanein R E; Lieberman A; Koller W C
Gene-toxin interaction as a putative risk factor for Parkinson's disease with dementia.
Neuroepidemiology 1998;17(2):96-104.
1997: Lyons K E; Pahwa R; Troster A I; Koller W C
A comparison of Parkinson's disease symptoms and self-reported functioning and well being.
Parkinsonism & related disorders 1997;3(4):207-9.
1997: Miyawaki E; Lyons K; Pahwa R; Tröster A I; Hubble J; Smith D; Busenbark K; McGuire D; Michalek D; Koller W C
Motor complications of chronic levodopa therapy in Parkinson's disease.
Clinical neuropharmacology 1997;20(6):523-30.
1997: Burns J M; Wilkinson S; Kieltyka J; Overman J; Lundsgaarde T; Tollefson T; Koller W C; Pahwa R; Troster A I; Lyons K E; Batnitzky S; Wetzel L; Gordon M A
Analysis of pallidotomy lesion positions using three-dimensional reconstruction of pallidal lesions, the basal ganglia, and the optic tract.
Neurosurgery 1997;41(6):1303-16; discussion 1316-8.
1997: Hubble J P; Busenbark K L; Pahwa R; Lyons K; Koller W C
Clinical expression of essential tremor: effects of gender and age.
Movement disorders : official journal of the Movement Disorder Society 1997;12(6):969-72.
1997: Koller W C
Essential tremor: the beginning of a new era.
Movement disorders : official journal of the Movement Disorder Society 1997;12(6):841.
1997: Paolo A M; Tröster A I; Ryan J J; Koller W C
Comparison of NART and Barona demographic equation premorbid IQ estimates in Alzheimer's disease.
Journal of clinical psychology 1997;53(7):713-22.
1997: Tröster A I; Fields J A; Wilkinson S B; Pahwa R; Miyawaki E; Lyons K E; Koller W C
Unilateral pallidal stimulation for Parkinson's disease: neurobehavioral functioning before and 3 months after electrode implantation.
Neurology 1997;49(4):1078-83.
1997: Pahwa R; Lyons K; McGuire D; Silverstein P; Zwiebel F; Robischon M; Koller W C
Comparison of standard carbidopa-levodopa and sustained-release carbidopa-levodopa in Parkinson's disease: pharmacokinetic and quality-of-life measures.
Movement disorders : official journal of the Movement Disorder Society 1997;12(5):677-81.
1997: Koller W; Pahwa R; Busenbark K; Hubble J; Wilkinson S; Lang A; Tuite P; Sime E; Lazano A; Hauser R; Malapira T; Smith D; Tarsy D; Miyawaki E; Norregaard T; Kormos T; Olanow C W
High-frequency unilateral thalamic stimulation in the treatment of essential and parkinsonian tremor.
Annals of neurology 1997;42(3):292-9.
1997: Miyawaki E; Meah Y; Koller W C
Serotonin, dopamine, and motor effects in Parkinson's disease.
Clinical neuropharmacology 1997;20(4):300-10.
1997: Koller W C; Montgomery E B
Issues in the early diagnosis of Parkinson's disease.
Neurology 1997;49(1 Suppl 1):S10-25.
1997: Pahwa R; Wilkinson S; Smith D; Lyons K; Miyawaki E; Koller W C
High-frequency stimulation of the globus pallidus for the treatment of Parkinson's disease.
Neurology 1997;49(1):249-53.
1997: Hubble J P; Busenbark K L; Wilkinson S; Pahwa R; Paulson G W; Lyons K; Koller W C
Effects of thalamic deep brain stimulation based on tremor type and diagnosis.
Movement disorders : official journal of the Movement Disorder Society 1997;12(3):337-41.
1997: Friedman J H; Koller W C; Lannon M C; Busenbark K; Swanson-Hyland E; Smith D
Benztropine versus clozapine for the treatment of tremor in Parkinson's disease.
Neurology 1997;48(4):1077-81.
1997: Burns J M; Wilkinson S; Overman J; Kieltyka J; Lundsgaarde T; Tollefson T; Koller W C; Pahwa R; Tröster A I; Lyons K E; Batnitzky S; Wetzel L; Gordon M A
Magnetic resonance image evaluation of pallidotomy lesions: a volumetric and shape analysis.
Neurosurgical focus 1997;2(3):e3.
1997: Koller W C
Neuroprotective therapy for Parkinson's disease.
Experimental neurology 1997;144(1):24-8.
1996: Paolo A M; Axelrod B N; Tröster A I; Blackwell K T; Koller W C
Utility of a Wisconsin Card Sorting Test short form in persons with Alzheimer's and Parkinson's disease.
Journal of clinical and experimental neuropsychology 1996;18(6):892-7.
1996: Koller W C
Selegiline monotherapy in the treatment of Parkinson's disease.
Neurology 1996;47(6 Suppl 3):S196-9.
1996: Busenbark K; Ramig L; Dromey C; Koller W C
Methazolamide for essential voice tremor.
Neurology 1996;47(5):1331-2.
1996: Pahwa R; Marjama J; McGuire D; Lyons K; Zwiebel F; Silverstein P; Ward R; Koller W C
Pharmacokinetic comparison of Sinemet and Atamet (generic carbidopa/levodopa): a single-dose study.
Movement disorders : official journal of the Movement Disorder Society 1996;11(4):427-30.
1996: Busenbark K; Barnes P; Lyons K; Ince D; Villagra F; Koller W C
Accuracy of reported family histories of essential tremor.
Neurology 1996;47(1):264-5.
1996: Giron L T; Koller W C
Methods of managing levodopa-induced dyskinesias.
Drug safety : an international journal of medical toxicology and drug experience 1996;14(6):365-74.
1996: Anouti A; Schmidt K; Lyons K E; Hubble J P; Schellenberg G; Golbe L I; Lang A E; Galvez-Jimenez N; Hershey L; Koller W C
Normal distribution of apolipoprotein E alleles in progressive supranuclear palsy.
Neurology 1996;46(4):1156-7.
1996: Hubble J P; Busenbark K L; Wilkinson S; Penn R D; Lyons K; Koller W C
Deep brain stimulation for essential tremor.
Neurology 1996;46(4):1150-3.
1996: Hutton J T; Koller W C; Ahlskog J E; Pahwa R; Hurtig H I; Stern M B; Hiner B C; Lieberman A; Pfeiffer R F; Rodnitzky R L; Waters C H; Muenter M D; Adler C H; Morris J L
Multicenter, placebo-controlled trial of cabergoline taken once daily in the treatment of Parkinson's disease.
Neurology 1996;46(4):1062-5.
1996: Pahwa R; Lyons K; McGuire D; Dubinsky R; Hubble J P; Koller W C
Early morning akinesia in Parkinson's disease: effect of standard carbidopa/levodopa and sustained-release carbidopa/levodopa.
Neurology 1996;46(4):1059-62.
1996: Olanow C W; Godbold J H; Koller W
Effect of adding selegeline to levodopa in early, mild Parkinson's disease. Patients taking selegeline may have received more levodopa than necessary.
BMJ (Clinical research ed.) 1996;312(7032):702-3; author reply 704-5.
1996: Anouti A; Koller W C
Diagnostic testing in movement disorders.
Neurologic clinics 1996;14(1):169-82.
1996: Glatt S L; Hubble J P; Lyons K; Paolo A; Tröster A I; Hassanein R E; Koller W C
Risk factors for dementia in Parkinson's disease: effect of education.
Neuroepidemiology 1996;15(1):20-5.
1996: Koller W C
Management of motor fluctuations in Parkinson's disease.
European neurology 1996;36 Suppl 1():43-8.
1996: Pahwa R; Koller W C
Treatment of Parkinson's disease with controlled-release Carbidopa/L-DOPA.
Advances in neurology 1996;69():487-91.
1995: Tröster A I; Stalp L D; Paolo A M; Fields J A; Koller W C
Neuropsychological impairment in Parkinson's disease with and without depression.
Archives of neurology 1995;52(12):1164-9.
1995: Olanow C W; Hauser R A; Gauger L; Malapira T; Koller W; Hubble J; Bushenbark K; Lilienfeld D; Esterlitz J
The effect of deprenyl and levodopa on the progression of Parkinson's disease.
Annals of neurology 1995;38(5):771-7.
1995: Paolo A M; Tröster A I; Axelrod B N; Koller W C
Construct validity of the WCST in normal elderly and persons with Parkinson's disease.
Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists 1995;10(5):463-73.
1995: Hubble J P; Cao T; Kjelstrom J A; Koller W C; Beaman B L
Nocardia species as an etiologic agent in Parkinson's disease: serological testing in a case-control study.
Journal of clinical microbiology 1995;33(10):2768-9.
1995: Hurwitz A; Hubble J P; Glatt S L; Koller W C; Pollack J
Erythrocyte thiolmethyltransferase: another failed marker for Alzheimer's and Parkinson's diseases.
Neurology 1995;45(10):1903-6.
1995: Beyer P L; Palarino M Y; Michalek D; Busenbark K; Koller W C
Weight change and body composition in patients with Parkinson's disease.
Journal of the American Dietetic Association 1995;95(9):979-83.
1995: Hubble J P; Koller W C; Cutler N R; Sramek J J; Friedman J; Goetz C; Ranhosky A; Korts D; Elvin A
Pramipexole in patients with early Parkinson's disease.
Clinical neuropharmacology 1995;18(4):338-47.
1995: Lang A E; Koller W C; Fahn S
Psychogenic parkinsonism.
Archives of neurology 1995;52(8):802-10.
1995: Pahwa R; Koller W C
Dopamine agonists in the treatment of Parkinson's disease.
Cleveland Clinic journal of medicine 1995;62(4):212-7.
1995: Paolo A M; Tröster A I; Glatt S L; Hubble J P; Koller W C
Differentiation of the dementias of Alzheimer's and Parkinson's disease with the dementia rating scale.
Journal of geriatric psychiatry and neurology 1995;8(3):184-8.
1995: Lang A E; Benabid A L; Koller W C; Lozano A M; Obeso J A; Olanow C W; Pollak P
The core assessment program for intracerebral transplantation.
Movement disorders : official journal of the Movement Disorder Society 1995;10(4):527-8.
1995: McDermott M P; Jankovic J; Carter J; Fahn S; Gauthier S; Goetz C G; Golbe L I; Koller W; Lang A E; Olanow C W
Factors predictive of the need for levodopa therapy in early, untreated Parkinson's disease. The Parkinson Study Group.
Archives of neurology 1995;52(6):565-70.
1995: Anouti A; Koller W C
Tremor disorders. Diagnosis and management.
The Western journal of medicine 1995;162(6):510-3.
1995: Marjama J; Tröster A I; Koller W C
Psychogenic movement disorders.
Neurologic clinics 1995;13(2):283-97.
1995: Pahwa R; Busenbark K; Swanson-Hyland E F; Dubinsky R M; Hubble J P; Gray C; Koller W C
Botulinum toxin treatment of essential head tremor.
Neurology 1995;45(4):822-4.
1995: Tröster A I; Paolo A M; Lyons K E; Glatt S L; Hubble J P; Koller W C
The influence of depression on cognition in Parkinson's disease: a pattern of impairment distinguishable from Alzheimer's disease.
Neurology 1995;45(4):672-6.
1995: Koller W C; Glatt S L; Hubble J P; Paolo A; Tröster A I; Handler M S; Horvat R T; Martin C; Schmidt K; Karst A
Apolipoprotein E genotypes in Parkinson's disease with and without dementia.
Annals of neurology 1995;37(2):242-5.
1995: Paolo A M; Tröster A I; Glatt S L; Hubble J P; Koller W C
Influence of demographic variables on the Dementia Rating Scale.
Journal of geriatric psychiatry and neurology 1995;8(1):38-41.
1995: Hubble J P; Koller W C
The parkinsonian personality.
Advances in neurology 1995;65():43-8.
1994: Koller W C; Silver D E; Lieberman A
An algorithm for the management of Parkinson's disease.
Neurology 1994;44(12 Suppl 10):S1-52.
1994: Gordon M F; Weiner W J; Koller W C; Rao T H; Chehebar V; Dickson D W
Case 2, 1994: parkinsonism and cognitive impairment.
Movement disorders : official journal of the Movement Disorder Society 1994;9(6):679-86.
1994: Koller W C; Pahwa R
Treating motor fluctuations with controlled-release levodopa preparations.
Neurology 1994;44(7 Suppl 6):S23-8.
1994: Koller W C; Busenbark K; Miner K
The relationship of essential tremor to other movement disorders: report on 678 patients. Essential Tremor Study Group.
Annals of neurology 1994;35(6):717-23.
1994: Calne D B; Duvoisin R C; Koller W C
Individualizing therapy in patients with disabling Parkinson's disease symptoms.
Neurology 1994;44(3 Suppl 1):S8-11.
1993: Dubinsky R M; Gray C S; Koller W C
Essential tremor and dystonia.
Neurology 1993;43(11):2382-4.
1993: Hubble J P; Venkatesh R; Hassanein R E; Gray C; Koller W C
Personality and depression in Parkinson's disease.
The Journal of nervous and mental disease 1993;181(11):657-62.
1993: Hubble J P; Cao T; Hassanein R E; Neuberger J S; Koller W C
Risk factors for Parkinson's disease.
Neurology 1993;43(9):1693-7.
1993: Hubble J P; Pahwa R; Michalek D K; Thomas C; Koller W C
Interactive video conferencing: a means of providing interim care to Parkinson's disease patients.
Movement disorders : official journal of the Movement Disorder Society 1993;8(3):380-2.
1993: Pahwa R; Busenbark K; Gray C; Koller W C
Identical twins with similar onset of Parkinson's disease: a case report.
Neurology 1993;43(6):1159-61.
1993: Busenbark K; Pahwa R; Hubble J; Hopfensperger K; Koller W; Pogrebra K
Double-blind controlled study of methazolamide in the treatment of essential tremor.
Neurology 1993;43(5):1045-7.
1993: Pahwa R; Busenbark K; Huber S J; Michalek D; Hubble J P; Koller W C
Clinical experience with controlled-release carbidopa/levodopa in Parkinson's disease.
Neurology 1993;43(4):677-81.
1993: Hubble J P; Koller W C; Waters C
Effects of selegiline dosing on motor fluctuations in Parkinson's disease.
Clinical neuropharmacology 1993;16(1):83-7.
1993: Pahwa R; Koller W C
Is there a relationship between Parkinson's disease and essential tremor?
Clinical neuropharmacology 1993;16(1):30-5.
1992: Bejar J M; Kepes J; Koller W C
Hemiballism and tremor due to ependymal cyst.
Movement disorders : official journal of the Movement Disorder Society 1992;7(4):370-2.
1992: Koller W C; Rope S D; Huber S J; Blumenthal D C; Blumenthal H J
Metabolism of glucurolactone to glucarate in Parkinson's disease.
Neurology 1992;42(9):1807-8.
1992: Busenbark K L; Huber S J; Greer G; Pahwa R; Koller W C
Olfactory function in essential tremor.
Neurology 1992;42(8):1631-2.
1992: Lang A; Quinn N; Marsden C D; Findley L; Koller W; Brin M; Fahn S
Essential tremor.
Neurology 1992;42(7):1432-4.
1992: Busenbark K; Pahwa R; Hubble J; Koller W
The effect of acetazolamide on essential tremor: an open-label trial.
Neurology 1992;42(7):1394-5.
1992: Hopfensperger K; Koller W C
Non-parkinsonian tremor.
Current opinion in neurology and neurosurgery 1992;5(3):321-3.
1992: Koller W C; Busenbark K; Gray C; Hassanein R S; Dubinsky R
Classification of essential tremor.
Clinical neuropharmacology 1992;15(2):81-7.
1992: Koller W C
When does Parkinson's disease begin?
Neurology 1992;42(4 Suppl 4):27-31; discussion 41-8.
1992: Koller W C
How accurately can Parkinson's disease be diagnosed?
Neurology 1992;42(1 Suppl 1):6-16; discussion 57-60.
1992: Koller W C
Controlled-release carbidopa-levodopa: old drug--new drug. Introduction.
Neurology 1992;42(1 Suppl 1):4-5; discussion 57-60.
1992: Koller W C
Initiating treatment of Parkinson's disease.
Neurology 1992;42(1 Suppl 1):33-8; discussion 57-60.
1991: Busenbark K L; Nash J; Nash S; Hubble J P; Koller W C
Is essential tremor benign?
Neurology 1991;41(12):1982-3.
1991: Goetz C G; Stebbins G T; Klawans H L; Koller W C; Grossman R G; Bakay R A; Penn R D
United Parkinson Foundation Neurotransplantation Registry on adrenal medullary transplants: presurgical, and 1- and 2-year follow-up.
Neurology 1991;41(11):1719-22.
1991: Koller W C
A new drug for treatment of essential tremor? Time will tell.
Mayo Clinic proceedings. Mayo Clinic 1991;66(10):1085-7.
1991: Koller W C; Block G A; Ahlskog J E; Ahrens S; Cedarbaum J M; Cyhan G; Goetz C G; LeWitt P A; Liss C; McLean L
Effect of MK-458 (HPMC) in Parkinson's disease previously untreated with dopaminergic drugs. A double-blind, placebo-controlled multicenter study.
Clinical neuropharmacology 1991;14(4):322-9.
1991: Koller W C; Langston J W; Hubble J P; Irwin I; Zack M; Golbe L; Forno L; Ellenberg J; Kurland L; Ruttenber A J
Does a long preclinical period occur in Parkinson's disease?
Geriatrics 1991;46 Suppl 1():8-15.
1991: Langston J W; Koller W C
Preclinical detection of Parkinson's disease. The next frontier: presymptomatic detection. Introduction.
Geriatrics 1991;46 Suppl 1():5-7.
1991: Hopfensperger K; Koller W C
Recognizing early Parkinson's disease.
Postgraduate medicine 1991;90(1):49-50, 55-6, 59.
1991: Dubinsky R M; Gray C S; Vetere-Overfield B; Koller W C
Electromyographic guidance of botulinum toxin treatment in cervical dystonia.
Clinical neuropharmacology 1991;14(3):262-7.
1991: Koller W C; Langston J W; Hubble J P; Irwin I; Zack M; Golbe L; Forno L; Ellenberg J; Kurland L; Ruttenber A J
Does a long preclinical period occur in Parkinson's disease?
Neurology 1991;41(5 Suppl 2):8-13.
1991: Langston J W; Koller W C
The next frontier in Parkinson's disease: presymptomatic detection.
Neurology 1991;41(5 Suppl 2):5-7.
1991: Dubinsky R M; Gray C; Husted D; Busenbark K; Vetere-Overfield B; Wiltfong D; Parrish D; Koller W C
Driving in Parkinson's disease.
Neurology 1991;41(4):517-20.
1991: Wong G F; Gray C S; Hassanein R S; Koller W C
Environmental risk factors in siblings with Parkinson's disease.
Archives of neurology 1991;48(3):287-9.
1991: Truong D D; Dubinsky R; Hermanowicz N; Olson W L; Silverman B; Koller W C
Posttraumatic torticollis.
Archives of neurology 1991;48(2):221-3.
1991: Waxman M J; Morantz R A; Koller W C; Paone D B; Nelson P W
High incidence of cardiopulmonary complications associated with implantation of adrenal medullary tissue into the caudate nucleus in patients with advanced neurologic disease.
Critical care medicine 1991;19(2):181-6.
1990: Biary N; Koller W; Langenberg P
Correlation between essential tremor and migraine headache.
Journal of neurology, neurosurgery, and psychiatry 1990;53(12):1060-2.
1990: Olanow C W; Koller W; Goetz C G; Stebbins G T; Cahill D W; Gauger L L; Morantz R; Penn R D; Tanner C M; Klawans H L
Autologous transplantation of adrenal medulla in Parkinson's disease. 18-month results.
Archives of neurology 1990;47(12):1286-9.
1990: Koller W C; Vetere-Overfield B; Williamson A; Busenbark K; Nash J; Parrish D
Sexual dysfunction in Parkinson's disease.
Clinical neuropharmacology 1990;13(5):461-3.
1990: Koller W C; Hubble J P
Levodopa therapy in Parkinson's disease.
Neurology 1990;40(10 Suppl 3):suppl 40-7; discussion 47-9.
1990: Jankovic J; McDermott M; Carter J; Gauthier S; Goetz C; Golbe L; Huber S; Koller W; Olanow C; Shoulson I
Variable expression of Parkinson's disease: a base-line analysis of the DATATOP cohort. The Parkinson Study Group.
Neurology 1990;40(10):1529-34.
1990: Waxman M J; Durfee D; Moore M; Morantz R A; Koller W
Nutritional aspects and swallowing function of patients with Parkinson's disease.
Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition 1990;5(5):196-9.
1990: Koller W C; Giron L T
Selegiline HC1: Selective MAO-type B inhibitor.
Neurology 1990;40(10 Suppl 3):suppl 58-60.
1990: Koller W; Vetere-Overfield B; Gray C; Alexander C; Chin T; Dolezal J; Hassanein R; Tanner C
Environmental risk factors in Parkinson's disease.
Neurology 1990;40(8):1218-21.
1990: Koller W; Vetere-Overfield B; Gray C; Dubinsky R
Failure of fixed-dose, fixed muscle injection of botulinum toxin in torticollis.
Clinical neuropharmacology 1990;13(4):355-8.
1990: Murrow R W; Schweiger G D; Kepes J J; Koller W C
Parkinsonism due to a basal ganglia lacunar state: clinicopathologic correlation.
Neurology 1990;40(6):897-900.
1990: Koller W C
Evaluation of tremor disorders.
Hospital practice (Office ed.) 1990;25(5A):23, 26-7, 30-1.
1990: Samie M R; Selhorst J B; Koller W C
Post-traumatic midbrain tremors.
Neurology 1990;40(1):62-6.
1990: Goetz C G; Stebbins G T; Klawans H L; Koller W C; Grossman R G; Bakay R A; Penn R D
United Parkinson Foundation Neurotransplantation Registry: multicenter US and Canadian data base, presurgical and 12 month follow-up.
Progress in brain research 1990;82():611-7.
1990: Koller W C; Waxman M; Morantz R
Adrenal neural transplants in Parkinson's disease.
Advances in neurology 1990;53():559-65.
1990: Koller W C; Findley L J
Psychogenic tremors.
Advances in neurology 1990;53():271-5.
1989: Hubble J P; Busenbark K L; Koller W C
Essential tremor.
Clinical neuropharmacology 1989;12(6):453-82.
1989: Koller W C; Vetere-Overfield B
Acute and chronic effects of propranolol and primidone in essential tremor.
Neurology 1989;39(12):1587-8.
1989: Koller W C; Vetere-Overfield B; Barter R
Tremors in early Parkinson's disease.
Clinical neuropharmacology 1989;12(4):293-7.
1989: Koller W; Lang A; Vetere-Overfield B; Findley L; Cleeves L; Factor S; Singer C; Weiner W
Psychogenic tremors.
Neurology 1989;39(8):1094-9.
1989: Koller W C; Morantz R; Vetere-Overfield B; Waxman M
Autologous adrenal medullary transplant in progressive supranuclear palsy.
Neurology 1989;39(8):1066-8.
1989: Koller W C; Huber S J
Tremor disorders of aging: diagnosis and management.
Geriatrics 1989;44(5):33-6, 41.
1989: Koller W C; Glatt S; Vetere-Overfield B; Hassanein R
Falls and Parkinson's disease.
Clinical neuropharmacology 1989;12(2):98-105.
1989: Koller W C
Tradozone in essential tremor. Probe of serotoninergic mechanisms.
Clinical neuropharmacology 1989;12(2):134-7.
1989: Koller W C
Task-specific dystonias.
Neurology 1989;39(3):457.
1989: Goetz C G; Olanow C W; Koller W C; Penn R D; Cahill D; Morantz R; Stebbins G; Tanner C M; Klawans H L; Shannon K M
Multicenter study of autologous adrenal medullary transplantation to the corpus striatum in patients with advanced Parkinson's disease.
The New England journal of medicine 1989;320(6):337-41.
1989: Koller W C; Vetere-Overfield B
Usefulness of a writing aid in writer's cramp.
Neurology 1989;39(1):149-50.
1989: Biary N; Cleeves L; Findley L; Koller W
Post-traumatic tremor.
Neurology 1989;39(1):103-6.
1989: Koller W C; Biary N M
Volitional control of involuntary movements.
Movement disorders : official journal of the Movement Disorder Society 1989;4(2):153-6.
1989: Koller W C; Wong G F; Lang A
Posttraumatic movement disorders: a review.
Movement disorders : official journal of the Movement Disorder Society 1989;4(1):20-36.
1988: Cleeves L; Findley L J; Koller W
Lack of association between essential tremor and Parkinson's disease.
Annals of neurology 1988;24(1):23-6.
1988: Zdonczyk D; Royse V; Koller W C
Nicotine and tremor.
Clinical neuropharmacology 1988;11(3):282-6.
1988: Koller W C; Herbster G
D1 and D2 dopamine receptor mechanisms in dopaminergic behaviors.
Clinical neuropharmacology 1988;11(3):221-31.
1988: Barr A N; Fischer J H; Koller W C; Spunt A L; Singhal A
Serum haloperidol concentration and choreiform movements in Huntington's disease.
Neurology 1988;38(1):84-8.
1988: Koller W C
Idiopathic oral-facial dyskinesia.
Advances in neurology 1988;49():177-83.
1987: Koller W; Orebaugh C; Lawson L; Potempa K
Pindolol-induced tremor.
Clinical neuropharmacology 1987;10(5):449-52.
1987: Koller W C; Herbster G
Adjuvant therapy of parkinsonian tremor.
Archives of neurology 1987;44(9):921-3.
1987: Koller W C; Rubino F; Gupta S
Pharmacologic probe with progabide of GABA mechanisms in essential tremor.
Archives of neurology 1987;44(9):905-6.
1987: Koller W C; Glatt S; Biary N; Rubino F A
Essential tremor variants: effect of treatment.
Clinical neuropharmacology 1987;10(4):342-50.
1987: Koller W; Herbster G; Anderson D; Wack R; Gordon J
Quinpirole hydrochloride, a potential anti-parkinsonism drug.
Neuropharmacology 1987;26(8):1031-6.
1987: Findley L J; Koller W C
Essential tremor: a review.
Neurology 1987;37(7):1194-7.
1987: Koller W C; Lang A E
Age of onset of Parkinson's disease.
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 1987;14(2):179-80.
1987: Koller W C; Herbster G
Terguride, a mixed dopamine agonist-antagonist, in animal models of Parkinson's disease.
Neurology 1987;37(4):723-7.
1987: Biary N; Koller W
Kinetic predominant essential tremor: successful treatment with clonazepam.
Neurology 1987;37(3):471-4.
1987: Gordon J H; Clopton J K; Curtin J C; Koller W C
Chronic autoreceptor blockade and neuroleptic-induced dopamine receptor hypersensitivity.
Pharmacology, biochemistry, and behavior 1987;26(2):223-8.
1987: Koller W; Cone S; Herbster G
Caffeine and tremor.
Neurology 1987;37(1):169-72.
1987: Shale H; Fahn S; Koller W C; Lang A E
What is it? Case 1, 1987: unusual tremors, bradykinesia, and cerebral lucencies.
Movement disorders : official journal of the Movement Disorder Society 1987;2(4):321-38.
1987: Biary N; Koller W C
Essential tongue tremor.
Movement disorders : official journal of the Movement Disorder Society 1987;2(1):25-9.
1987: Koller W; O'Hara R; Weiner W; Lang A; Nutt J; Agid Y; Bonnet A M; Jankovic J
Relationship of aging to Parkinson's disease.
Advances in neurology 1987;45():317-21.
1987: Krusz J C; Koller W C; Ziegler D K
Historical review: abnormal movements associated with epidemic encephalitis lethargica.
Movement disorders : official journal of the Movement Disorder Society 1987;2(3):137-41.
1987: Koller W; Herbster G; Gordon J
PHNO, a novel dopamine agonist, in animal models of parkinsonism.
Movement disorders : official journal of the Movement Disorder Society 1987;2(3):193-9.
1986: Koller W C; Fields J Z; Gordon J H; Perlow M J
Evaluation of ciladopa hydrochloride as a potential anti-Parkinson drug.
Neuropharmacology 1986;25(9):973-9.
1986: Koller W C
Paraquat and Parkinson's disease.
Neurology 1986;36(8):1147.
1986: Koller W; Biary N; Cone S
Disability in essential tremor: effect of treatment.
Neurology 1986;36(7):1001-4.
1986: Quinn N P; Koller W C; Lang A E; Marsden C D
Painful Parkinson's disease.
Lancet 1986;1(8494):1366-9.
1986: Koller W; O'Hara R; Nutt J; Young J; Rubino F
Monozygotic twins with Parkinson's disease.
Annals of neurology 1986;19(4):402-5.
1986: Koller W C
Ineffectiveness of phenoxybenzamine in essential tremor.
Journal of neurology, neurosurgery, and psychiatry 1986;49(2):222.
1986: Koller W C; Martyn B
Writing tremor: its relationship to essential tremor.
Journal of neurology, neurosurgery, and psychiatry 1986;49(2):220.
1986: Koller W C
Pharmacologic treatment of parkinsonian tremor.
Archives of neurology 1986;43(2):126-7.
1986: Koller W C
Dose-response relationship of propranolol in the treatment of essential tremor.
Archives of neurology 1986;43(1):42-3.
1986: Koller W C; Royse V L
Efficacy of primidone in essential tremor.
Neurology 1986;36(1):121-4.
1986: Koller W; Kase S
Muscle strength testing in Parkinson's disease.
European neurology 1986;25(2):130-3.
1986: Koller W; Herbster G; Cone S
Clonidine in the treatment of essential tremor.
Movement disorders : official journal of the Movement Disorder Society 1986;1(4):235-7.
1985: Koller W; O'Hara R; Dorus W; Bauer J
Tremor in chronic alcoholism.
Neurology 1985;35(11):1660-2.
1985: Biary N; Koller W
Handedness and essential tremor.
Archives of neurology 1985;42(11):1082-3.
1985: Koller W C; Royse V L
Time course of a single oral dose of propranolol in essential tremor.
Neurology 1985;35(10):1494-8.
1985: Koller W C; Trimble J
The gait abnormality of Huntington's disease.
Neurology 1985;35(10):1450-4.
1985: Koller W C; Glatt S L; Fox J H
Senile gait. A distinct neurologic entity.
Clinics in geriatric medicine 1985;1(3):661-9.
1985: Wolf M E; Koller W C
Tardive dystonia: treatment with trihexyphenidyl.
Journal of clinical psychopharmacology 1985;5(4):247-8.
1985: Koller W C; Rubino F A
Combined resting-postural tremors.
Archives of neurology 1985;42(7):683-4.
1985: Koller W C; Musa M N
Amitriptyline-induced abnormal movements.
Neurology 1985;35(7):1086.
1985: Koller W C
Long-acting propranolol in essential tremor.
Neurology 1985;35(1):108-10.
1985: Koller W; Graner D; Mlcoch A
Essential voice tremor: treatment with propranolol.
Neurology 1985;35(1):106-8.
1984: Koller W C
Attenuation by pergolide of haloperidol-induced striatal dopamine receptor density.
Journal of clinical psychopharmacology 1984;4(6):343-5.
1984: Koller W C
Amantadine in essential tremor.
Annals of neurology 1984;16(5):621-2.
1984: Koller W C
The diagnosis of Parkinson's disease.
Archives of internal medicine 1984;144(11):2146-7.
1984: Koller W C; Wilson R S; Glatt S L; Fox J H
Motor signs are infrequent in dementia of the Alzheimer type.
Annals of neurology 1984;16(4):514-6.
1984: Koller W C; Davenport J
Genetic testing in Huntington's disease.
Annals of neurology 1984;16(4):511-3.
1984: Wolf M E; Koller W C; Mosnaim A D
Electroencephalogram in tardive dyskinesia.
Clinical EEG (electroencephalography) 1984;15(4):222-5.
1984: Koller W C
Diagnosis and treatment of tremors.
Neurologic clinics 1984;2(3):499-514.
1984: Koller W C
Propranolol therapy for essential tremor of the head.
Neurology 1984;34(8):1077-9.
1984: Koller W C
Sensory symptoms in Parkinson's disease.
Neurology 1984;34(7):957-9.
1984: Koller W C
Disturbance of recent memory function in parkinsonian patients on anticholinergic therapy.
Cortex; a journal devoted to the study of the nervous system and behavior 1984;20(2):307-11.
1984: Koller W C
Adult-onset foot dystonia.
Neurology 1984;34(5):703.
1984: Koller W C
Pharmacologic trials in the treatment of cerebellar tremor.
Archives of neurology 1984;41(3):280-1.
1984: Koller W C; Biary N
Metoprolol compared with propranolol in the treatment of essential tremor.
Archives of neurology 1984;41(2):171-2.
1984: Koller W C; Biary N
Effect of alcohol on tremors: comparison with propranolol.
Neurology 1984;34(2):221-2.
1984: Koller W C
Effects of intermittent haloperidol treatment on dopamine receptor sensitivity in guinea pigs.
Psychopharmacology 1984;84(1):98-100.
1983: Glatt S L; Wilson R S; Koller W C; Fox J H
Cortical disinhibitory signs.
Neurology 1983;33(10):1391-3.
1983: Koller W C
Alcoholism in essential tremor.
Neurology 1983;33(8):1074-6.
1983: Koller W C
Nadolol in essential tremor.
Neurology 1983;33(8):1076-7.
1983: Nausieda P A; Bieliauskas L A; Bacon L D; Hagerty M; Koller W C; Glantz R N
Chronic dopaminergic sensitivity after Sydenham's chorea.
Neurology 1983;33(6):750-4.
1983: Koller W C
Prevalence of spontaneous lingual-facial-buccal dyskinesias.
Neurology 1983;33(5):669-70.
1983: Koller W C; Biary N
Lithium ineffective in dystonia.
Annals of neurology 1983;13(5):579-80.
1983: Koller W C
Alcohol and Parkinson disease.
Annals of neurology 1983;13(4):467.
1983: Koller W C
Edentulousness and oral dyskinesia.
The American journal of psychiatry 1983;140(4):510.
1983: Koller W C; Wilson R S; Glatt S L; Huckman M S; Fox J R
Senile gait: correlation with computed tomographic scans.
Annals of neurology 1983;13(3):343-4.
1983: Koller W C
Dysfluency (stuttering) in extrapyramidal disease.
Archives of neurology 1983;40(3):175-7.
1983: Koller W C
Edentulous orodyskinesia.
Annals of neurology 1983;13(1):97-9.
1983: Koller W C
Intermittent levodopa therapy in parkinsonism.
Advances in neurology 1983;37():45-50.
1982: Koller W C
Weekly drug holiday in PD.
Neurology 1982;32(12):1406-7.
1982: Koller W C; Glatt S; Wilson R S; Fox J H
Primitive reflexes and cognitive function in the elderly.
Annals of neurology 1982;12(3):302-4.
1982: Koller W C
Cerebellar atrophy and schizophrenia.
The American journal of psychiatry 1982;139(6):846-7.
1982: Koller W C; Barr A; Biary N
Estrogen treatment of dyskinetic disorders.
Neurology 1982;32(5):547-9.
1982: Koller W C
Alternate day levodopa therapy in parkinsonism.
Neurology 1982;32(3):324-6.
1981: Koller W C; Glatt S L; Fox J H; Kaszniak A W; Wilson R S; Huckman M S
Cerebellar atrophy: relationship to aging and cerebral atrophy.
Neurology 1981;31(11):1486-8.
1981: Koller W C; Weiner W J; Perlik S; Nausieda P A; Goetz C G; Klawans H L
Complications of chronic levodopa therapy: long-term efficacy of drug holiday.
Neurology 1981;31(4):473-6.
1981: Koller W C; Glatt S L; Perlik S; Huckman M S; Fox J H
Cerebellar atrophy demonstrated by computed tomography.
Neurology 1981;31(4):405-12.
1981: Nausieda P A; Koller W C; Weiner W J; Klawans H L
Pemoline-induced chorea.
Neurology 1981;31(3):356-60.
1981: Koller W C
Estrogen in experimental tardive dyskinesia.
Neurology 1981;31(2):226-8.
1980: Weiner W J; Koller W C; Perlik S; Nausieda P A; Klawans H L
Drug holiday and management of Parkinson disease.
Neurology 1980;30(12):1257-61.
1980: Perlik S J; Koller W C; Weiner W J; Nausieda P; Klawans H L
Parkinsonism: is your treatment appropriate?
Geriatrics 1980;35(11):65-70, 74.
1980: Koller W C; Weiner W J; Diamond B I; Nausieda P A; Klawans H L
The pharmacological evaluation of pergolide mesylate as a potential anti-parkinson agent.
Neuropharmacology 1980;19(9):831-7.
1980: Koller W C; Glatt S L; Fox J H
Phenytoin-induced cerebellar degeneration.
Annals of neurology 1980;8(2):203-4.
1980: Koller W C; Weiner W J; Klawans H L; Nausieda P A
Influence of female sex hormones on neuroleptic-induced behavioral supersensitivity.
Neuropharmacology 1980;19(4):387-91.
1980: Nausieda P A; Grossman B J; Koller W C; Weiner W J; Klawans H L
Sydenham chorea: an update.
Neurology 1980;30(3):331-4.
1980: Koller W C; Klawans H L
Cerebellar calcification on computerized tomography.
Annals of neurology 1980;7(2):193-4.
1979: Nausieda P A; Koller W C; Weiner W J; Klawans H L
Chorea induced by oral contraceptives.
Neurology 1979;29(12):1605-9.
1979: Koller W C; Weiner W J; Nausieda P A; Klawans H L
Bromocriptine: decreased clinical effects at higher dosages.
Neurology 1979;29(10):1439-40.
1979: Nausieda P A; Koller W C; Weiner W J; Klawans H L
Modification of postsynaptic dopaminergic sensitivity by female sex hormones.
Life sciences 1979;25(6):521-6.
1979: Koller W C; Cochran J W; Klawans H L
Calcification of the basal ganglia: computerized tomography and clinical correlation.
Neurology 1979;29(3):328-33.
1979: Koller W C; Diamond B I; Weiner W J; Nausieda P A; Klawans H L
Effect of pergolide mesylate, an ergoline, in animal models of Parkinson's disease: implications for therapy.
Transactions of the American Neurological Association 1979;104():161-4.
1979: Nausieda P A; Koller W C; Weiner W J; Klawans H L
Clinical and experimental studies of phenytoin-induced hyperkinesias.
Journal of neural transmission 1979;45(4):291-305.
1978: Nausieda P A; Koller W C; Klawans H L; Weiner W J
Phenytoin and choreic movements.
The New England journal of medicine 1978;298(19):1093-4.
1977: Koller W C; Gehlmann L K; Malkinson F D; Davis F A
Dapsone-induced peripheral neuropathy.
Archives of neurology 1977;34(10):644-6.
1977: Gehlman L K; Koller W C; Malkinson F D
Dapsone-induced neuropathy.
Archives of dermatology 1977;113(6):845-6.
1976: Koller W C; Berry C A
Alteration of basal ganglia evoked responses by reserpine and L-dopa.
Psychopharmacology 1976;49(3):281-5.
1976: Koller W C; Berry C A
Modification of evoked responses in the caudate nucleus by cholinergic agents.
Neuropharmacology 1976;15(4):233-8.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

William Koller

Research Profile (preview)

Disorders

Chemicals & Drugs

Procedures

Anatomy

Concepts & Ideas

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of William Koller (preview)

All Publications